Kiniksa to host conference call

Conference call to discuss Phase 2 clinical data and its recently initiated pivotal Phase 3 clinical trial of rilonacept in subjects with recurrent pericarditis will be held on December 11 at 9 am.

Webcast: https://investors.kiniksa.com/news-events/events
https://thefly.com/landingPageNews.php?id=2835191